# Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

> **NCT06527872** · — · RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 300 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **OTHER:** None (Observational study)

## Key facts

- **NCT ID:** NCT06527872
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-04
- **Primary completion:** 2029-03-29
- **Final completion:** 2029-03-29
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06527872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06527872, "Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06527872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*